B-cell-depleting therapy in systemic lupus erythematosus.
about
Cellular targeting in autoimmunityAntibodies in the pathogenesis of hypertensionRationale for B cell targeting in SLEA rare case of prototheca algaemia in a patient with systemic lupus erythematosus and recent belimumab infusion.In-/off-label use of biologic therapy in systemic lupus erythematosus.Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.B cell encounters with apoptotic cells.Primary Sjögren syndrome: an update on current pharmacotherapy options and future directions.Importance of reverse signaling of the TNF superfamily in immune regulation.Targeted therapies in systemic lupus erythematosus.B-cell-targeted therapies in systemic lupus erythematosus and ANCA-associated vasculitis: current progress.Cogan's syndrome--clinical guidelines and novel therapeutic approaches.Classification criteria and treatment modalities in primary Sjögren's syndrome.Biologicals for the treatment of systemic lupus erythematosus: current status and emerging therapies.Human effector B lymphocytes express ARID3a and secrete interferon alpha.B cells gone rogue: the intersection of diffuse large B cell lymphoma and autoimmune disease.Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.CD20+ B cell depletion in systemic autoimmune diseases: common mechanism of inhibition or disease-specific effect on humoral immunity?Screening epitopes on systemic lupus erythematosus autoantigens with a peptide array.New Treatments for Systemic Lupus Erythematosus on the Horizon: Targeting Plasmacytoid Dendritic Cells to Inhibit Cytokine Production.Detection of epitopes in systemic lupus erythematosus using peptide microarray.Treatment options in paraneoplastic disorders of the peripheral nervous system.
P2860
Q26824580-671C7AC5-6327-48B3-B2FC-39907B743302Q26828588-7CAE8692-50F2-46B5-B90D-B1FA27059F1EQ33829700-AC549D02-67DA-46D5-9DA7-78B41FA448B9Q34394509-E00B0E0D-4DD3-4017-BD84-5D576EBF71DDQ35094536-DBC10089-A394-4874-AC13-5F48907B8AD5Q37062514-EEDD37A3-B193-4560-8E8D-A1BD96033240Q38065216-37DEE6D0-1B07-4978-BE48-44FA582E62B4Q38076460-D1F2C734-8145-412D-A2A4-63ACAFF7DE13Q38096027-B706AE17-5C7B-4DF0-93DB-564309BA3468Q38130443-66252C1E-A6A6-4F35-AC71-095A546FB1D2Q38131034-5089C7F4-B400-495A-843A-CF517C9DA32BQ38175351-8ED07839-D77D-4DAA-83D5-9D22E18733DBQ38197287-9EB47D7C-05BB-452C-81D7-5D4F0479DF20Q38289398-3D5B307E-4AE9-4389-BB8B-73DE6EF01929Q38291271-1D2287B0-3A26-4077-AD70-FB449AE213D9Q38813104-C084919D-E055-485B-9D86-ED57BD631BC5Q38903851-87387712-F1F4-495D-9B8F-B31A0EE2C72BQ42356199-25D0DFF4-5020-4DF4-86FE-4A90BE5F35D5Q45376906-6631859C-5130-4D66-9D0E-3DE187BBA495Q49499785-ACADAFBD-95BF-4182-9B1C-B902AD3B3068Q51147794-01778099-8784-4C6D-8A18-8CDD0BFDD80EQ51838886-BD8D0505-DBDF-4612-9753-CC3AC2C48B98
P2860
B-cell-depleting therapy in systemic lupus erythematosus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
B-cell-depleting therapy in systemic lupus erythematosus.
@en
B-cell-depleting therapy in systemic lupus erythematosus.
@nl
type
label
B-cell-depleting therapy in systemic lupus erythematosus.
@en
B-cell-depleting therapy in systemic lupus erythematosus.
@nl
prefLabel
B-cell-depleting therapy in systemic lupus erythematosus.
@en
B-cell-depleting therapy in systemic lupus erythematosus.
@nl
P2093
P2860
P1476
B-cell-depleting therapy in systemic lupus erythematosus.
@en
P2093
Iñaki Sanz
John H Stone
Xavier Bosch
P2860
P304
P356
10.1016/J.AMJMED.2011.09.010
P407
P577
2012-04-01T00:00:00Z